<scp>L</scp>-Carnitine-conjugated nanoparticles to promote permeation across blood–brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2
Longfa Kou(Wenzhou Medical University), Jin Sun(Shenyang Pharmaceutical University), Weiling Guo(Weifang Medical University), Yanxian Hou(Shenyang Pharmaceutical University), Vadivel Ganapathy(Texas Tech University), Gang Wang(Yangzhou University), Zhonggui He(Shenyang Pharmaceutical University), Qiang Fu(Shenyang Pharmaceutical University), Menglin Wang(Shenyang Pharmaceutical University), Qing Yao(Wenzhou Medical University)
Cited by 80
Related Papers
GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon
|Cancer Research|2009|765
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
|Frontiers in Pharmacology|2018|295
Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines
|Nano Letters|2014|250
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy
|Journal of Controlled Release|2019|162
Solid self-emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation
|International Journal of Pharmaceutics|2009|138